Cash And Equivalent Changement Date
AbbVie USD 13.29B 4.53B 2023-09
Amgen USD 10.94B 23.8B 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Aurora Cannabis CAD 234.94M 23.77M 2023-03
Bausch Health Companies USD 760M 181M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Canopy Growth CAD 240.38M 168.05M 2023-09
Catalent USD 229M 20M 2023-12
Corcept Therapeutics USD 425.4M 313.6M 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
GlaxoSmithKline GBP 3.18B 37M 2023-09
J&J USD 3.5B 497M 2023-09
Merck USD 8.6B 2.94B 2023-09
Pacira USD 153.3M 54.18M 2023-12
Perrigo USD 598.3M 43.1M 2023-09
Pfizer USD 3.15B 516M 2023-09
Phibro Animal Health USD 43.15M 1.87M 2023-09
Prestige Brands USD 63.61M 3.55M 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Supernus Pharmaceuticals USD 75.05M 19.93M 2023-12
Takeda JPY 318.05B 1.67B 2023-09
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
Zoetis USD 2.04B 288M 2023-12



Glaxosmithkline Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.